Sengenics
Sengenics, a leading biotechnology company headquartered in Singapore (SG), specialises in the field of immunology and proteomics. Founded in 2013, the company has rapidly established itself as a key player in the development of innovative diagnostic solutions and personalised medicine. Sengenics is renowned for its unique KREX™ platform, which enables the identification of disease-associated biomarkers, setting it apart in the competitive landscape of the biotechnology industry. With a strong operational presence across Asia and beyond, Sengenics has achieved significant milestones, including collaborations with prominent research institutions and healthcare providers. The company’s commitment to advancing precision medicine has positioned it as a trusted partner in the healthcare sector, contributing to improved patient outcomes through its cutting-edge products and services.
DitchCarbon Score
How does Sengenics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sengenics's score of 6 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sengenics's reported carbon emissions
Sengenics Corporate Pte Ltd, headquartered in Singapore, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 emissions by 42% by 2030, using 2021 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. In addition to its Scope 1 and Scope 2 commitments, Sengenics is also focused on measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. These initiatives reflect the company's dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. As a small to medium enterprise, Sengenics is actively contributing to global climate efforts while striving for operational efficiency and environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sengenics is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
